Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status
Letter 2024 en
Authors
RB
Roger Olofsson Bagge
RM
Rasmus Mikiver
MM
Michael A. Marchetti
Abstract
1 min read
This study confirmed the statistical performance of both the MSKCC and limited MIA models in a large, nationally representative data set. However, decision curve analysis demonstrated that using the models only improved selection for SLNB compared to biopsy in all patients when a risk threshold of at least 7% was used, with the greatest benefit seen for T2 melanomas at a threshold of 10%. Care should be taken when using these nomograms to guide selection for SLNB at the lowest thresholds.
Rasmus Mikiver, Roger Olofsson Bagge, Michael A. Marchetti, Alexander Christopher Jonathan Van Akkooi, Daniel G. Coit, Christian Ingvar, Karolin Isaksson, Richard A Scolyer, John F. Thompson, Alexander H. R. Varey, Johan Lyth, Edmund K. Bartlett
Caroline G. Watts, Andrew J. Spillane, Michael A. Henderson, Anne Ε. Cust, Jeffrey Braithwaite, DE Gyorki, AM Hong, Kelly Jw, GV Long, VJ Mar, AM Menzies, Rachael L. Morton, Frances Rapport, Rpm Saw, Helen Schmid, Richard A Scolyer, Al Smith, Abigail Winder, GJ Mann
Serigne Lo, Mary‐Ann El Sharouni, Karijn P.M. Suijkerbuijk, Tasnia Ahmed, Witkamp Arjen, Anne Ε. Cust, V. Sigurdsson, P. J. van Diest, Richard A Scolyer, Carla H. van Gils, John F. Thompson
Alexander H. R. Varey, Isabel Li, Mary‐Ann El Sharouni, Julie M. Simon, Aikaterini Dedeilia, Sydney Ch’ng, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Thomas E. Pennington, Michael Rtshiladze, Jonathan R. Stretch, Omgo E. Nieweg, Alexander C.J. van Akkooi, Ryan J. Sullivan, Genevieve M. Boland, Jeffrey E. Gershenwald, P. J. van Diest, Richard A Scolyer, Georgina V. Long, John F. Thompson, Serigne Lo
Discussion(0)
No comments yet. Be the first to comment.